Why are post-op treatment protocols important? What does it take to establish a treatment protocol successfully in your practice? Our panel of experts answers these questions and more, while also providing useful tips for you and your practice.
Please see Indication and Important Safety Information below
Download and share these resources with your practice and patients.
PROLENSA® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
Click here for full prescribing information on PROLENSA®
PROLENSA is a trademark of Bausch & Lomb Incorporated or its affiliates. Any other products/brand names are trademarks of the respective owners.